Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-01

Clinical Trial Update: Rituximab and Targeted Nursing for Pediatric Nephrotic Syndrome [NA]

View source ↗

Summary

The clinical trial evaluating rituximab plus targeted nursing for pediatric nephrotic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)

Snippet

Sponsor: Wuhan Children's Hospital | Conditions: Nephrotic Syndrome in Children | NA | Status: COMPLETED